Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Arsenal Bio

Main focus: Next-generation autologous T cell therapies

Company stage: Commercial

Diseases (gene editing): Cancer

Genome editing tool: CRISPR

Funding stage: Private

Location: South San Francisco, CA, USA

Website: https://www.arsenalbio.com/

Gene editing partnerships: Bristol Myers Squibb

Arsenal Bio develops multiple proprietary technology platforms, CellFoundry™, PrimeR™ and CARchitecture™ which together with the CRISPR technology form the foundation for its next-generation therapies. While the company has yet to disclose its lead programmes, it has announced a collaboration with Bristol Myers Squibb (BMS) where the two companies will discover and develop T cell therapies for the treatment of solid tumours.

Tags

HashtagArsenalBio

Company: Arsenal Bio
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine